PPA
RMD icon

Pacific Point Advisors’s ResMed RMD Stock Holding History

Pacific Point Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$295K Sell
1,515
-11
-0.7% -$2.28K 0.13% 104
2026
Q1 		$343K Buy
1,526
+11
+0.7% +$2.74K 0.18% 106
2025
Q4 		$365K Sell
1,515
-4,726
-76% -$1.21M 0.2% 105
2025
Q3 		$1.71M Buy
6,241
+21
+0.3% +$5.74K 1% 22
2025
Q2 		$1.6M Buy
6,220
+341
+6% +$81.3K 0.87% 27
2025
Q1 		$1.32M Buy
5,879
+573
+11% +$134K 0.73% 40
2024
Q4 		$1.28M Buy
+5,306
New +$1.28M 0.78% 37

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pacific Point Advisors's RMD Position: Q2 2026 in Review

Pacific Point Advisors reduced its ResMed (RMD) stake by 0.72% in Q2 2026, selling an estimated $2.28K and leaving 1,515 shares worth $295K. The position accounts for 0.13% of the portfolio, ranked #104.

Pacific Point Advisors first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.71M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Pacific Point Advisors held 1,515 shares of ResMed worth $295K as of Q2 2026.
  • Pacific Point Advisors sold 11 ResMed shares in Q2 2026, an estimated $2.28K.
  • ResMed made up 0.13% of Pacific Point Advisors's portfolio in Q2 2026, its #104 holding.
  • Pacific Point Advisors first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Pacific Point Advisors's ResMed position peaked at $1.71M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Pacific Point Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.